Literature DB >> 10898509

Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway.

V Apostolopoulos1, G A Pietersz, S Gordon, L Martinez-Pomares, I F McKenzie.   

Abstract

Antigens such as MUC1 coupled to oxidized mannan lead to rapid and efficient MHC class I presentation to CD8+ cells and a preferential T1 response; after reduction there is class II presentation and a T2 immune response. We now show that the selective advantage of the oxidized mannan-MUC1 is due to the presence of aldehydes and not Schiff bases, and that oxidized mannan-MUC1 binds to the mannose and not scavenger receptors and is internalized and presented by MHC class I molecules 1,000 times more efficiently than when reduced. After internalization there is rapid access to the class I pathway via endosomes but not lysosomes, proteasomal processing and transport to the endoplasmic reticulum, Golgi apparatus and cell surface. Aldehydes cause rapid entry into the class I pathway, and can therefore direct the subsequent immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898509     DOI: 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

Review 1.  Carbohydrate-based cancer vaccines: target cancer with sugar bullets.

Authors:  Chang-Cheng Liu; Xin-Shan Ye
Journal:  Glycoconj J       Date:  2012-06-06       Impact factor: 2.916

Review 2.  Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.

Authors:  Benjamin G Keselowsky; Chang Qing Xia; Michael Clare-Salzler
Journal:  Hum Vaccin       Date:  2011-01-01

3.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

4.  Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.

Authors:  Samar Hamdy; Azita Haddadi; Anooshirvan Shayeganpour; John Samuel; Afsaneh Lavasanifar
Journal:  Pharm Res       Date:  2011-05-11       Impact factor: 4.200

5.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

6.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Authors:  Kuo-Ching Sheng; Dodie S Pouniotis; Mark D Wright; Choon Kit Tang; Eliada Lazoura; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

7.  Mannan-mediated gene delivery for cancer immunotherapy.

Authors:  Choon K Tang; Jodie Lodding; Gabriela Minigo; Dodie S Pouniotis; Magdalena Plebanski; Anja Scholzen; Ian F C McKenzie; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

8.  Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.

Authors:  Naoya Miura; Hidetaka Akita; Naho Tateshita; Takashi Nakamura; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

9.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

10.  miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation.

Authors:  S E M Heinsbroek; M L Squadrito; R Schilderink; F W Hilbers; C Verseijden; M Hofmann; A Helmke; L Boon; M E Wildenberg; J J T H Roelofs; C Y Ponsioen; C P Peters; A A Te Velde; S Gordon; M De Palma; W J de Jonge
Journal:  Mucosal Immunol       Date:  2015-11-04       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.